All Stories

  1. Air pollution and pulmonary arterial hypertension. Outcomes in a referral center from Mexico City

    Article • September 2020, European Respiratory Society (ERS)

    Prof Tomas Pulido

  2. Macitentan in the treatment of pulmonary arterial hypertension

    Article • Future Cardiology, July 2020, Future Medicine

    Prof Tomas Pulido

  3. Angiotensin converting enzyme 2 and angiotensin (1–7) axis in pulmonary arterial hypertension

    Article • European Respiratory Journal, April 2020, European Respiratory Society (ERS)

    JULIO SANDOVAL, Prof Tomas Pulido

  4. Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical Trial

    Article • American Journal of Respiratory and Critical Care Medicine, March 2020, American Thoracic Society

    Prof Tomas Pulido

  5. Integrating Data From Randomized Controlled Trials and Observational Studies to Assess Survival in Rare Diseases

    Article • Circulation Cardiovascular Quality and Outcomes, May 2019, Wolters Kluwer Health

    Prof Tomas Pulido

  6. Evaluation of Macitentan in Patients With Eisenmenger Syndrome

    Article • Circulation, January 2019, Wolters Kluwer Health

    Prof Tomas Pulido, Rolf Berger

  7. Risk stratification and medical therapy of pulmonary arterial hypertension

    Article • European Respiratory Journal, January 2019, European Respiratory Society (ERS)

    Professor Nazzareno Galie, Prof Tomas Pulido, Professor Zhi-Cheng JING

  8. Advances in medical therapy for pulmonary arterial hypertension

    Article • Current Opinion in Cardiology, January 2019, Wolters Kluwer Health

    Prof Tomas Pulido

  9. Pulmonary Vasoreactivity and Phenotypes in Pulmonary Arterial Hypertension Associated to Connective Tissue Diseases

    Article • Revista de investigaci�n Cl�nica, April 2018, Publicidad Permanyer, SLU

    Prof Tomas Pulido

  10. Association between six-minute walk distance and long-term outcomes in patients with pulmonary arterial hypertension: Data from the randomized SERAPHIN trial

    Article • PLoS ONE, March 2018, PLOS

    Professor Rogerio Souza, Professor Olivier SITBON, Prof Tomas Pulido

  11. Pulmonary Arterial Hypertension-Related Morbidity Is Prognostic for Mortality

    Article • Journal of the American College of Cardiology, February 2018, Elsevier

    Professor Rogerio Souza, Professor Olivier SITBON, Prof Tomas Pulido

  12. Macitentan in Pulmonary Arterial Hypertension: A Focus on Combination Therapy in the SERAPHIN Trial

    Article • American Journal of Cardiovascular Drugs, December 2017, Springer Science + Business Media

    Prof Tomas Pulido

  13. Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study

    Article • BMC Pulmonary Medicine, December 2017, Springer Science + Business Media

    Prof Tomas Pulido

  14. SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension

    Article • European Heart Journal, February 2017, Oxford University Press (OUP)

    Professor Nazzareno Galie, Professor Rogerio Souza, Professor Olivier SITBON, Prof Tomas Pulido

  15. Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension

    Article • CHEST Journal, January 2017, Elsevier

    Professor Rogerio Souza, Professor Olivier SITBON, Prof Tomas Pulido

  16. De la tromboembolia pulmonar aguda a la hipertensión pulmonar tromboembólica crónica: implicaciones en la patobiología y fisiopatología

    Article • Archivos de Cardiología de México, January 2017, Publicidad Permanyer, SLU

    Prof Tomas Pulido

  17. Persistent pulmonary hypertension and right ventricular function after percutaneous mechanical thrombectomy in severe acute pulmonary embolism

    Article • European Respiratory Journal, October 2016, European Respiratory Society (ERS)

    Prof Tomas Pulido

  18. Interventional and surgical therapeutic strategies for pulmonary arterial hypertension: Beyond palliative treatments

    Article • Journal of Cardiology, October 2015, Elsevier

    Prof Tomas Pulido

  19. Use of responder threshold criteria to evaluate the response to treatment in the phase III CHEST-1 study

    Article • The Journal of Heart and Lung Transplantation, March 2015, Elsevier

    Prof Tomas Pulido